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ABSTRACT  
Proteolysis of the multimeric blood coagulation protein von Willebrand Factor (VWF) by 
ADAMTS13 is crucial for prevention of microvascular thrombosis. ADAMTS13 cleaves VWF 
within the mechanosensitive A2 domain, which is believed to open under shear flow. Here, we 
combine Fluorescence Correlation Spectroscopy (FCS) and a microfluidic shear cell to monitor 
real-time kinetics of full-length VWF proteolysis as a function of shear stress. For comparison, 
we also measure the Michaelis-Menten kinetics of ADAMTS13 cleavage of wild-type VWF in 
the absence of shear but partially denaturing conditions. Under shear, ADAMTS13 activity on 
full-length VWF arises without denaturing agent as evidenced by FCS and gel-based multimer 
analysis. In agreement with Brownian hydrodynamics simulations, we find a sigmoidal increase 
of the enzymatic rate as a function of shear at a threshold shear rate 2/1γ!  = 5522/s. The same 
flow-rate dependence of ADAMTS13 activity we also observe in blood plasma, which is 
relevant to predict hemostatic dysfunction. 
INTRODUCTION  
In the event of vascular injury, the multimeric plasma protein von Willebrand Factor (VWF) 
mediates platelet adhesion, aggregation, and crosslinking to maintain hemostasis [1,2]. VWF is 
either constitutively secreted into the circulation or is stored in Weibel-Palade bodies and 
released in the form of ultralarge multimers in response to physiological and pathophysiological 
stimuli [3]. A carefully controlled balance of VWF binding to platelets, and VWF cleavage by 
ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motif, member 13) 
[4-6] is required for hemostasis. In this context, fluid shear stress plays an important role: It 
initially activates the binding of the VWF A1 domain to platelets, and regulates over time 
additionally VWF degradation by opening the A2 domain, exposing the cleavage site for 
ADAMTS13 [7,8]. Hence, force-controlled activation and cleavage of VWF is part of a feedback 
loop that balances hemostasis. Absence of ADAMTS13 causes the life-threatening disease 
thrombotic thrombocytopenic purpura (TTP), which is characterized by uncontrolled 
microvascular thrombosis [5,9]. ADAMTS13 may also control the size distribution of VWF in 
the circulation, since the effect of shear stress depends on the hydrodynamic drag and hence on 
the size of VWF multimers [10]. 
The mechanism of shear-induced unfolding of VWF has been explored in several studies in the 
recent past [11,12]. VWF is cleaved by breakage of the Tyr1605-Met1606 bond in its A2 
domain, which is a deeply buried cleavage site [13,14]. The interaction of immobilized VWF or 
VWF fragments with ADAMTS13 fragments or variants has been characterized in buffer using 
ELISAs [7,15]. Recognition of recombinant VWF fragments by recombinant ADAMTS13 has 
been examined under both denaturing [16] and non-denaturing conditions [17]. In a seminal 
study by Zhang et al. using laser tweezers, force was applied directly to single A2 domains in 
buffer and the dependence of the catalytic rate on the enzyme concentration was measured [14]. 
Pulling at the ends of polymeric molecules results in a homogenous force profile along the 
polymer chain under equilibrium conditions. However, simulations of unfolding under shear 
flow reveal that the intramolecular forces in VWF are fluctuating and size dependent [18,19]. 
Therefore, cleavage probabilities under shear flow are expected to show a pronounced size 
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dependence and more and less susceptible intramolecular regions may exist. In particular, 
ADAMTS13 is not expected to act on the full-length protein in the same fashion as on isolated 
fragments. 
We have recently shown that Fluorescence Correlation Spectroscopy (FCS) allows one to 
measure the size distribution of VWF [20]. In addition, FCS can be used to monitor binding in 
complex fluids such as blood plasma [21] and provides information on macromolecular 
dynamics [22-24]. This is of particular interest for studies of VWF, since it is assumed that 
unidentified enhancers of ADAMTS13 activity are present in plasma, whose effects cannot be 
mimicked in experiments performed in buffer [25]. Moreover, since the sample size required is 
very small, FCS studies can easily be combined with microfluidic devices [26,27]. 
In this paper, we study the cleavage of VWF multimers by ADAMTS13 under shear flow in 
aqueous buffer as well as in blood plasma. Using FCS, we detect the breakdown of recombinant 
VWF-eGFP fusion protein (rVWF) by measuring the increase in molar VWF concentration. A 
specially designed shear cell, combined with a FCS setup, allows us to monitor the cleavage of 
full-length rVWF as a function of shear flow. With this approach, we analyzed VWF cleavage 
under denaturing conditions as a reference and the observed Michaelis-Menten constant was 
compared with that obtained for the disease-related mutant VWF-G1629E, which is abnormally 
sensitive to proteolysis [17]. We showed that cleavage of rVWF under shear flow in blood 
plasma can be followed over time. In normal plasma (NP), enhanced proteolytic activity was 
found, presumably due to hitherto unknown accessory factors. We then determined cleavage 
rates as a function of shear rate. In agreement with Brownian hydrodynamics simulations, the 
shear dependence is sigmoidal with a half-maximum shear rate 2/1γ!  = 5522/s. Theoretical 
modeling enabled us to calculate the probability of the A2 domain to be accessible to cleavage 
by ADAMTS13 from the distribution of tension along a coarse-grained polymer model of VWF. 
RESULTS 
Cleavage of full-length rVWF follows Michaelis-Menten kinetics. In this study, we adopted a 
novel approach to study VWF proteolysis, based on the use of recombinant VWF-eGFP fusion 
(rVWF) as substrate. Each VWF monomer is thus labeled with a single eGFP unit, and therefore 
cleavage of the rVWF-eGFP multimers results in an increase in the number of fluorescent 
molecules. We monitor this increase using the amplitude of the fluorescence correlation signal, 
G(0), which is inversely proportional to the average particle number N in the detection volume 
(see Figure 1a and Supporting Material S1). To test this concept, we first performed cleavage 
experiments in denaturing buffer (5 mM Tris, pH 8.0, with 10 mM BaCl2, 1,5 M urea) that 
unfolds VWF in the absence of shear (Figure 1b-d). Figure 1b displays the decrease in G(0) with 
cleavage over time, which reflects an increase in the molar concentration of rVWF multimers 
(CVWF). The derived rVWF concentration increased linearly in time, with the cleavage rate kCR = 
dCVWF/dt depending on the ADAMTS13 concentration CA used (Figure 1c). For constant 
amounts of ADAMTS13, the cleavage rates increased hyperbolically as a function of the VWF 
concentration (Figure 1d). We fitted the curves with Michaelis-Menten kinetics 
kCR= kcatCA ⋅CmVWF KM +CmVWF( ) .    (1) 
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The substrate concentration CmVWF = m CVWF corresponds to the concentration of VWF monomers 
with the mean monomer number m = 5.6 (see Supporting Material S1). Imposing the constraint 
that the Michaelis-Menten constant KM does not depend on the concentration of ADAMTS13, 
we obtain the global Michaelis-Menten constant KM = (962 ± 480) nM and the catalytic rate 
constant kcat = (1.1 ± 0.4)×10-3/s for the physiological ADAMTS13 concentration (1 µg/ml), 
designated here as 1 U/ml. A tenfold increase in protease concentration (10 U/ml) resulted in a 
reduced rate constant to kcat = (1.8 ± 0.6)×10-4/s. The goodness of the fit for kcat is, however, 
limited, and this might explain the unexpected decrease in this parameter at the higher 
ADAMTS13 concentrations. Autoproteolysis of ADAMTS13 at high concentrations may also 
play a role. 
Cleavage of the mutant rVWF-G1629E. Next, we asked whether ADAMTS13 cleaves disease-
related VWF mutants with altered kinetics. We studied VWF-G1629E, which carries a mutation 
within the A2 domain near the site cleaved by ADAMTS13, as schematically depicted in Figure 
2a. The G1629E mutation is believed to keep the domain permanently unfolded [17]. In 
agreement with this assumption, strong ADAMTS13 activity was detected even at zero shear. In 
order to compare the cleavage rates with those for wild-type rVWF, we plotted the mutant data 
together with the ADAMTS13 activity previously measured under denaturing conditions. 
Strikingly, the rates are comparable, although the enzyme concentration used in the mutant case 
is 200-fold lower (0.05 instead of 10 U/ml), (Figure 2b). However, it must be noted that the wild-
type measurements were made under denaturing conditions, while the mutant was in buffer. For 
this reason we performed additional measurements comparing the proteolysis of the destabilized 
mutant rVWF-G1629E in buffer with and without urea. We found that the differences were not 
measurable within the experimental uncertainty (Supporting Material S2). Hence we assume that 
denaturing buffer has no strong impact on ADAMTS13 activity other than making the cleavage 
sites available in case of wild type VWF. This confirms that the mutant VWF is far more 
susceptible to proteolysis than the wild-type, leading to the loss of large multimers and 
ultimately to the significant bleeding symptoms seen in patients with the mutation G1629E. 
Shear-induced rVWF cleavage. We studied the dependence of ADAMTS13-mediated rVWF 
cleavage under defined shear flow. To this end, a miniaturized shear cell was built that could be 
mounted on a microscope stage in combination with an FCS setup. We chose a Mooney-type 
design for the shear cell, consisting of a cylindrical container and a rotating inner cylinder with a 
conical tip, which generates constant shear rates throughout the sample volume of 150µl (see 
Figure 3a). This device allowed us to monitor enzyme activity under shear flow with shear rates 
up to 10.000/s. Since FCS measurements rely on diffusion, shearing and FCS data sampling had 
to be run in an alternating mode: The solution was sheared and VWF cleaved for 15 min, and 
this was followed by a 15-min FCS detection period in the absence of shear, during which the 
VWF concentration was determined (Figure 3a). A typical experiment consisted of 16 such 
cycles. Neglecting the very short time scale of ramping, we consider steady shear flow 
throughout the experiment. At zero shear rate, γ!  = 0/s, cleavage rates were very low, less than 
2 pM/min. Thus, no appreciable change in VWF concentration is expected during the detection 
periods. However, higher shear rates did indeed result in increasing rVWF concentrations 
(Figure 3b). The full shear rate dependence was studied for cleavage of 10 nM rVWF at two 
different ADAMTS13 concentrations in buffer, with applied shear rates ranging from 0/s to 
10.000/s (Figure 3c,d). The data show negligible enzymatic activity at low shear rates, with 
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cleavage rates equivalent to that at zero shear, which is at the limit of resolution of the 
experiment. Significantly lower cleavage rates were detected for 1 U/ml ADAMTS13 compared 
to 10 U/ml. The increase in ADAMTS13 activity with shear can be described by different 
functional fits such as an exponential dCVWF / dt( !γ ) =α ⋅exp( !γ / !γc ) , in which case a characteristic 
shear rate !γc  = (1090 ± 44)/s is obtained for both ADAMTS13 concentrations (Figure 3c,d 
dashed lines). A power law dCVWF / dt( !γ ) =α ⋅ !γ n  equally well describes the data and results in 
the exponents nU1 = 2.7 and nU10 = 3.6 for the concentrations 1U/ml and 10U/ml, respectively. 
(see bold dotted lines in Figure 3c,d). At even higher shear rates, above 5000/s, an ill-defined 
regime appears, where FCS correlation curves indicate fluorescent objects with larger 
hydrodynamic radius rather than decreasing size. Since also the particle number concentration 
decreases in this regime, we assume that aggregation of the VWF multimers occurs. This process 
appears to be irreversible and the aggregates impede determination of reliable cleavage rates. 
Details of the course of aggregation, which might be due to shear-induced opening of 
intermolecular binding sites, are given in Supporting Material S3. 
To corroborate the degradation of rVWF cleavage by ADAMTS13 under shear, we monitored 
the multimer distribution in the time course of a shear experiment using gel analysis (Figure 
3e,f). Samples consisting of rVWF added to normal plasma (NP) were sheared at γ!  = 0, 2700, 
4000, 7500, and 10,000/s for 140 min. Gels were loaded with successive subsamples taken every 
20 minutes. While no change in the multimer size distribution was observed up to a shear rate of 
γ!  = 2700/s, large multimers disappeared with increasing shear rate above γ!  = 4000/s (Figure 3e). 
Figure 3f exemplarily shows an enlarged view of the rapidly fading multimer size distribution as 
a function of shear time at the highest shear rate γ!  = 10,000/s. Note that under the conditions in 
normal plasma we did not observe VWF aggregation at high shear rates, while in the 
measurements in buffer we observed the formation of aggregates for shear rates above 5000/s. 
Hydrodynamic Computer Simulations. Our experiments show that rates of cleavage by 
ADAMTS13 in the regime of elevated shear rates very sensitively depend on the precise shear 
rate and that, in agreement with the general belief, mutations in the A2 domain can dramatically 
lower the shear rate at which cleavage becomes significant. In order to corroborate the concept of 
shear-induced opening of the A2 cleavage domain, we compared the measured shear-dependent 
cleavage rates with simulations of the tension profile in unfolded VWF. To this end, we modeled 
the VWF polymer as a chain of weakly aggregating beads connected by stiff springs and 
performed Brownian dynamics simulations including hydrodynamic interactions [18,28,29]. In 
our simulation model, spherical beads of radius a represent VWF's repeating units (dimers), 
which interact with a cohesive strength ε. Rescaled shear rates γτ were used, with the 
characteristic diffusion time of a single bead being given by τ = 6πηa3/kT. Thus, by appropriate 
rescaling the simulation results can be interpreted in terms of arbitrary values of radius and 
viscosity η. In order to obtain physical units the viscosity η = 1.2x10-3 Pas and temperature T = 
310K were used. The remaining parameters are the bead radius a and the cohesive strength ε, 
which strongly influence the shear rate at which shear-induced unfolding of the polymeric 
globule sets in. The cohesive parameter was set at ε = 2 kT, such that, in the absence of shear 
flow, the polymer is collapsed. The unfolding transition occurs at a rescaled shear rate 𝛾𝜏 = 10 
[18], which translates to the experimental value of about 5000/s [11] when we set the bead radius 
to a = 73nm. Note that the unfolding transition is accompanied with maximal fluctuations of the 
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polymer size due to shear-induced unfolding and refolding, as shown in the Supporting Material 
S4. We calculated tension profiles along the chain of beads under shear flow as a function of 
polymer size and shear rate (Figure 4). Figure 4a shows the profile of the average tension along 
the VWF polymer for a representative polymer size of 20 beads (tension profiles of 10mer and 
30mer are depicted in Supporting Material S4). For the smallest shear rate, the force is maximal 
at the polymer termini. With increasing shear rate, the maximal forces move toward the chain 
center. Strong fluctuations are indicated by the high standard deviation σ, shown in the bottom of 
Figure 4a, and the corresponding broad tension distributions, shown for the middle bead i = 10 in 
Figure 4b. While fluctuations are larger than the average tensile forces (Figure 4a), the effect of 
increasing shear rate is more pronounced for the average force. Therefore, we analyze in the 
following the average tension profiles rather than fluctuations in order to study the shear-induced 
cleavage process. Typical snapshots of the 20mer unfolded by shear flow are illustrated in Figure 
4c. In order to relate the tension profile to the cleavage activity, we calculate the equilibrium 
probability for a single subunit i to be open and accessible for cleavage by ADAMTS13 from the 
average tension fi ( !γ )  between adjacent beads 
Pi ( !γ ) =1/ (1+ exp(− fi ( !γ ) / fe ) /K0 ) .     (2) 
This expression is derived considering the reversible transition of a cleavage site from the closed 
to the open state, where K0 denotes the equilibrium constant in the absence of force and fe the 
effective force scale characterizing the force dependence of the probability Pi. As shown in the 
Supporting Material, the force scale fc of the closing transition dominates the effective force 
scale fe (S4, Data Analysis). Considering the entire multimer, we define the mean number of 
accessible cleavage sites, nopen (N, !γ ) =2 Pi ( !γ )i
N
∑  (two cleavage sites per dimer), and plot 
numerical results for different VWF dimer number N in Figure 4d for fe = 0.04 pN and K0 = 
0.0011. These parameters were obtained by mapping simulation results to the experimental data, 
as described below. In a phenomenological description, the shear dependence of nopen is well 
approximated by a sigmoidal function (lines) where the saturation value is proportional to the 
VWF size 2N and the half-maximum shear rate decreases with increasing N. To take this size 
dependence into account, we weight nopen according to the experimentally determined size 
distribution of VWF in blood plasma [20] and thereby obtain the size-average open probability  
nopen ( !γ ) = bN−1nopen (N, !γ )N∑ b
N−1
N∑ ,    (3) 
with base b = 0.64 (blue line, Figure 4d). 
Shear-induced cleavage in blood plasma. We were particularly interested in characterizing the 
shear dependence of VWF proteolysis in blood plasma (Figure 5). Therefore, rVWF-eGFP was 
added to patient's blood plasma and studied in the FCS-shear cell. In this case, no ADAMTS13 is 
added, since blood plasma contains natural ADAMTS13. In this setting, both the recombinant 
VWF as well as the endogenous unlabeled VWF serve as substrates for ADAMTS13. We 
assume that there is no difference in the binding activity of ADAMTS13 for labeled and 
endogenous VWF because the binding site of the eGFP molecule is at the C-terminal and thus 
spatially separated from the cleavage site. Because VWF multimerization occurs only in vivo, no 
exchange is expected between labeled and endogenous VWF during the experiment. For data 
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analysis, we estimate the concentration of unlabeled VWF to be 3 nM (see Supporting Material 
S1). Figure 5a shows the cleavage rate as a function of VWF concentration under denaturing 
conditions in 25% NP (0.25 U/ml ADAMTS13). For comparison, the plot also shows the data for 
1 U/ml ADAMTS13 in buffer (taken from Figure 1d). Dotted lines indicate fits of Equation (1) 
with the same value for KM = 962 nM but different kcat = (6.4 ± 0.5)×10-3/s (NP) and kcat = (1.1 ± 
0.4)×10-3/s (buffer). The patient's plasma used in Figure 5b contained anti-ADAMTS13 
autoantibodies (AB plasma) and cleavage rates are considerably reduced ((3.13 ± 1.5)pM/min 
instead of (18.24 ± 2.0)pM/min). Figure 5c shows the cleavage rate as a function of shear. 
Importantly, in agreement with the gel analysis shown in Figure 3e,f, we did not find any 
evidence for VWF aggregation in experiments with blood plasma. We were therefore able to 
measure VWF cleavage in blood plasma up to γ!  = 10.000/s. In order to exclude the possibility 
that VWF concentration might increase under high shear over time due to solvent evaporation, 
we carried out a control experiment on pure eGFP protein, which shows only a small 
concentration increase of 6% in buffer subjected to a shear rate of γ!  = 8400/s over 2.5h. Under 
shear, rVWF in 50% NP exhibits a sigmoidal increase in cleavage rates with increasing shear 
rates. For the 50% AB plasma with reduced ADAMTS13 activity, we find the same sigmoidal 
dependence on shear, but overall reduced cleavage rates. The dotted lines in Figure 5c are best 
fits with a phenomenological equation for the shear-dependent cleavage rate 
kCR ( !γ ) = kmax 1+ exp(−( !γ − !γ1/2 ) /Δ !γ )( ) ,    (4) 
where  denotes the half-maximum shear rate, at which half of the monomers are accessible to 
cleavage, and the parameter γ!Δ  determines the width of the transition. The values for kmax 
denote the maximal enzymatic rate in the case of fully accessible cleavage sites. These will 
depend on the ADAMTS13 concentration CA as described by the Michaelis-Menten kinetics 
(Equation (1)). We obtain as a best fit the half maximum shear rate  = (5522 ± 642)/s and 
width  = (1271 ± 371)/s and enzyme activity dependent prefactors kmax = (3.5 ± 0.4)×10-3 
nM/s and kmax = (1.4 ± 0.3)×10-3 nM/s for NP and AB plasma, respectively (Figure 5c, dotted 
lines). Notice that the half maximum shear rate is close to the critical shear rate of VWF 
unfolding (5000/s [11]) indicating the correlation between high cleavage activity and large 
polymer size fluctuations. The fact that the shear dependence of cleavage in both NP and AB 
plasma has the same shape is a strong indication that VWF A2 domain opening is the rate 
limiting mechanism, while the conditions in the blood plasma, primarily the concentration of 
available ADAMTS13, sets the maximal enzymatic rate. 
As seen in Figure 5c, the experimentally determined dependence of ADAMTS13 activity on 
shear is in good agreement with the hydrodynamic model. The central assumption that we make 
is that the cleavage rate CRk  depends on the shear-dependent mean number of accessible 
cleavage sites via the effective substrate concentration  
CmVWF = nopenCVWF       (5) 
that enters the Michaelis-Menten Equation (1), where nopen  is given by Equation (3). This is in 
contrast to measurements under denaturing conditions where the mean number of monomers m = 
5.6 was assumed. For the theoretical prediction, the same value for KM = 962 nM is used. Given 
2/1γ!
2/1γ!
Δ !γ
nopen
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fixed concentrations CA = 1.3 nM and CVWF = 13 nM, the simulation results for the cleavage rate 
(open blue symbols in Figure 5c) fit the experimental data for NP plasma (filled blue symbols) 
for adjusted fit parameters fe = 0.04 pN, K0 = 0.0011, and the catalytic rate constant for a single 
cleavage site kcat = 0.04/s. Notice that the length scale xekT/fe ≈ 100 nm is comparable to the 
double contour length of the A2 domain [14]. Using the same fit parameters for AB plasma 
(black symbols), we obtain as a best fit an effective ADAMTS13 concentration CA = 0.55 nM. 
Note that kcat = 0.04/s obtained in shear-dependent measurements (Figure 5c) is one order of 
magnitude larger than kcat = 0.0064/s obtained under denaturing conditions (Figure 5a). 
 
 
DISCUSSION 
Using FCS and recombinant rVWF-eGFP, we have measured the ADAMTS13 activity in real-
time. In denaturing buffer, we observed Michaelis-Menten kinetics with KM = 962 nM. This 
value is in good agreement with those obtained in recent experiments performed with VWF 
fragments: Zanardelli et al. measured KM = 1.61 µM (kcat = 0.14/s) by high pressure liquid 
chromatography for cleavage of a 16.9 kDa fragment of the VWF A2 domain [30]. In 
experiments using gel analysis and ELISA, Gao et al. obtained KM = 1.7 µM (kcat = 1.3/s) for 
cleavage of an A2 domain fragment consisting of amino acid residues Asp1596-Arg1668 [7]. 
Using a VWF fragment suited for fluorescence energy transfer studies, Di Stasio et al. measured 
KM = 4.6 µM (kcat = 0.03/s) at pH 6.0 [31]. The differences to the catalytic rate constants that we 
observed, kcat = 0.0011/s, and 0.00018/s, depending on the ADAMTS13 concentrations, 
presumably are related to the fact that the earlier studies investigate cleavage independently of 
substrate unfolding in presumably less physiological situations. Thus their values seem to reflect 
higher proteolytic activities than found in our work. However, our data, for the first time, yield 
rates of full-length VWF cleavage.  
The unfolding of VWF under shear is known as a globular-stretch transition and it has long been 
speculated that its susceptibility to proteolysis is modulated by shear-induced extension. For the 
cleavage experiments under shear, we used a custom-built shear cell. Multimer analysis proved 
that the size distribution of the sheared VWF sample shows the same characteristics than VWF 
samples cleaved in a static assay under denaturing conditions [32]. Using FCS, we quantified the 
shear dependence of the VWF breakdown exhibiting a sigmoidal dependence on shear with half 
maximum shear rate 2/1γ!  = 5522/s and width γ!Δ  = 1271/s. These findings are in line with earlier 
observation of abrupt onset of VWF unfolding as a function of shear rate using fluorescence 
microscopy and small-angle neutron scattering [11,12]. Our Brownian hydrodynamics 
simulations show that hydrodynamic shear flow is capable to unfold VWF multimers and 
suggest that the internal tension opens the A2 domains in a dynamic equilibrium. We calculated 
the probability of a single subunit to be open as a function of the average tensile force fi acting 
between two neighboring monomers. Comparing the simulation to experimental data yields an 
effective force scale fe = 0.04 pN, at which the A2 domain opening probability begins to 
increase. This value should be compared to the characteristic force scale of A2 unfolding, fβ = 
1.1pN, previously measured by force-induced unfolding of the isolated A2 domain using optical 
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tweezers [14]. In that study, unfolding forces were measured as a function of force loading rates. 
Clearly, the force at which A2 is fully unfolding as probed in force spectroscopy experiments is 
not the same force as required to render A2 domains accessible to ADAMTS13 cleavage under 
shear [8,14]. In fact, fe is found to be substantially smaller than fβ. It is interesting to note that in 
our two-state equilibrium model the force dependence of the opening and closing rates are 
different, and that the force scale of the closing rate dominates fe, which corroborates the 
difference between fe and fβ (see Supporting Material S4). Also Zhang et al. [14] determined the 
rate of A2 refolding. We compare the rates in the absence of force and thus the free energy 
difference between the two states. As a result, we obtain an estimate for the free energy 
difference ΔF = - ln(K0) kT = 6.8 kT, which is in good agreement to the single barrier A2 
unfolding and refolding kinetic model (6.6 kT) [14]. We consider this agreement surprising 
given the slightly different model assumptions that go into the analysis of the experimental data. 
In terms of enzyme activity, Zhang et al. determined a catalytic rate constant of 0.14/s for single, 
accessible A2 domains and varying enzyme concentration [14]. Since we measured shear-
induced cleavage of full-length VWF in blood plasma instead of unfolded fragments in buffer, 
the smaller rate constant that we obtained, kcat = 0.04/s, might not be surprising. 
Our study of the VWF proteolysis induced by shear flow represents closely the clinical relevant 
situation. Our model does not require a mechanical force-induced unfolding of the A2 domain 
but rather considers the cleavage in the context of a thermodynamic reversible two-state opening 
model, in which a full-length VWF molecule is subject to shear flow and hence includes size 
dependent effects of VWF cleavage. Since both VWF size distribution as well as local mutations 
in VWF’s A2 domain are known to affect the ADAMTS13 susceptibility, it is desirable to extend 
the shear-induced-opening model even further in order to bring atomistic models together with 
coarse-grained hydrodynamic model used in this work. In the future such approaches might be 
capable to relate mutations directly to hemostatic dysfunction.  
A second aspect of the work is the measurement of ADAMTS13 activity in its natural 
environment, namely blood plasma, which is of clinical importance. We determined the kinetics 
of rVWF-eGFP cleavage in 25% normal blood plasma and found that the rate of proteolysis 
under shear is increased relative to experiments performed in buffer. This finding corroborates a 
previous hypothesis, which suggested that certain components found in blood, such as 
coagulation factor VIII, increase VWF's susceptibility to cleavage [33]. Although, we did not 
study the effect of particular blood plasma components on our studies, it is known that the 
enhancement of proteolysis is attributed, inter alia, to the conformational change induced in 
VWF by the binding of factor VIII [34]. Furthermore, calcium is known to have a strong down-
regulating effect on VWF cleavage due to calcium-mediated stabilization of the A2 [35]. Other 
cofactors and their effects on VWF have not yet been studied, but might provide novel 
therapeutic targets. As a consequence, FCS-based measurements of rVWF-eGFP cleavage may 
have diagnostic potential. Determination of levels of ADAMTS13 activity in plasma is, for 
example, required for differential diagnostics in microangiopathies. FCS combined with 
recombinant VWF-eGFP added to patient samples permits detection of extremely low levels of 
ADAMTS13 activity. Even detection limits well below 5% can be achieved, if the extremely 
proteolysis-sensitive rVWF-G1629E is employed as a substrate. Furthermore, FCS can help to 
quantify the effect of VWF mutations and assess the impact of potential drugs. In this context, 
the ability to measure specific cleavage activity on VWF in native blood samples constitutes a 
valuable extension of available methods. In summary, quantitative assessment of shear-induced 
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enhancement of ADAMTS13 activity, both in vitro and in patient's blood samples, together with 
the fact that the data follow theoretical modeling, provide the means to shed light on the new 
territory of shear-dependent phenotypes in clinically relevant VWF mutations. 
 
MATERIALS AND METHODS 
Protein expression: The recombinant fusion protein rVWF-eGFP was expressed and purified as 
described in detail before [20]. For the mutant VWF-G1629E, the plasmid PIRESneo2-VWF-
G1629E-eGFP was used, which was produced by in vitro mutagenesis of wild-type pIRESneo2-
VWF-eGFP by replacing wild-type codon 1629 for glycine with the naturally occurring mutant 
codon specifying glutamic acid (p.Gly1629Glu). Wild-type rhuADAMTS13 used was produced 
as described in [17]. 
Plasma samples were taken from normal volunteer donors and collected in S-monovettes, 
coagulation sodium citrate (Sarstedt, Germany), incubated at room temperature (30 min), and 
centrifuged (10 min, 2300 rpm). The supernatant was aliquoted and stored at −80°C until use. 
Informed consent was obtained from all subjects. VWF concentration was measured to be 97%, 
i.e. in the normal range by an ELISA measuring collagen-binding capacity (MEDILYS 
Laborgesellschaft mbH, Hamburg, Germany). ADAMTS13 activity was obtained by an activity-
ELISA to be 113% (Technoclone, Vienna, Austria). 
Fluorescent Correlation Spectroscopy (FCS) measurements were performed on an Axiovert 
200 microscope with a ConfoCor 2 unit (Carl Zeiss, Jena, Germany), equipped with a 40x (NA = 
1.2) water-immersion Apochromat objective (Carl Zeiss). A 488 nm argon laser was used for 
illumination. For calibration, eGFP was measured for 20x60 s in the corresponding buffer. 
Experiments without shear flow were carried out in eight-well LabTek I chamber slides (Nunc, 
Rochester, NY) on rVWF for 20x15 min and on rVWF-G1629E for 20x9 min, (owing to its 
higher sensitivity to proteolysis). Correlation analysis was performed using the ConfoCor 2 
software. The FCS data analysis is described in detail in Supplementary Information S1. 
Shear cell: A custom-made shear cell was used to apply shear forces consisting of a combined 
cone-and-plate and concentric cylindrical design, called Mooney system [36]. A coverslip (Carl 
Roth, Karlsruhe, Germany) was fixed with nail varnish to a stainless steel sample holder 
containing wells of radii ro = 6.5 mm, serving as outer cylinders. The inner rotating cylinder 
(radius ri = 6.1 mm) was connected to a brushless motor with integrated controller (Faulhaber 
GmbH, Schönaich, Germany). Before use, both cylinders were first incubated for 30 min with 
UHT milk to avoid sticking of the sample to the surface, and then washed with buffer for at least 
ten times. For shear-flow measurements, periods of applied shear stress (15 min) without FCS 
recording alternated with measuring periods (5x3 min) without shear flow. 
Multimer analysis was performed by sodium dodecyl sulfate agarose gel electrophoresis in 
combination with immunoblotting and luminescent visualization [37]. The luminescent blot was 
stored on electronic media using photo imaging (FluorChem8000; Alpha Innotech, San Leandro, 
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CA) [38]. The sample consisted of 3 nM rVWF-eGFP in 5 mM Tris-HCl (pH 8.0) and 50% 
normal blood plasma. 
Cleavage protocol: Measurements were conducted in either buffer or blood plasma. The 
cleavage buffer contained 5 mM Tris-HCl (pH 8.0) with 10 mM BaCl2 for ADAMTS13 
activation [31,39]. For measurements without shear flow, 1.5 M urea was added to partially 
denature VWF based on the commonly used protocol [30,39,40]. For measurements in blood 
plasma, the plasma was diluted to the desired concentration with 5 mM Tris-HCl (pH 8.0). For 
all measurements, the temperature was set to 37°C (without shear: heating stage, ibidi GmbH, 
Martinsried, Germany; with shear: water bath, Julabo GmbH, Seelbach, Germany). 
Simulation methods: Brownian dynamics simulations were performed using a discretized 
Langevin equation, where hydrodynamic interactions are taken into account via the Rotne-Prager 
tensor [41] (for details, see Supporting Material S4). The VWF was modeled as a homopolymer 
consisting of N beads, which interact via Lennard-Jones potentials of depth ε = 2 kT, and are 
connected in a linear chain by harmonic bonds with a rescaled spring constant k = 200 kT/a2. 
Tensile forces acting along each bond ( )arkf iii 21, −= +  are recorded during the course of 
simulation. To compare the dimensionless quantities used in the simulation to physical values, 
we use the dimer radius a = 73 nm, the viscosity η = 1.2x10-3 Pas, and the temperature T = 310K. 
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FIGURES 
 
Figure 1. FCS analysis of the kinetics of full-length rVWF proteolysis in buffer. (a) The 
correlation curve G(τ) at correlation time 0 is proportional to the reciprocal of the number of 
fluorescent molecules in the detection volume N = 1/G(0), i.e. the molar concentration of VWF. 
For multimeric rVWF-eGFP with one eGFP molecule attached to each VWF monomer, cleavage 
by ADAMTS13 results in an increase in the number of fluorescent molecules. This increase in N 
concomitantly reduces the value of G(0) and can be detected in real-time. (b) Representative 
autocorrelation curves showing that proteolysis of VWF is reflected in a progressive decrease in 
amplitude G(τ) with time. (c) Molar concentration of rVWF molecules increases linearly over 
time and the cleavage rates depend on ADAMTS13 concentration. (d) The hyperbolic 
dependence of cleavage rate on VWF concentration was fitted with Equation (1) (lines). 
Constraining a Michaelis-Menten constant independent of the enzyme concentration, we 
obtained KM = 962 nM, and kcat = 0.0011/s and kcat = 0.00018/s for CA = 1 U/ml and CA = 10 U/ml, 
respectively. 
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Figure 2. Proteolysis of the disease-related mutant rVWF-G1629E. (a) Schematic drawing of the 
multidomain structure of a VWF monomer. The G1629E mutation is located close to the 
ADAMTS13 cleavage site (Y1605-M1606) and results in constitutive opening of the A2 domain. 
(b) Cleavage kinetics of rVWF-G1629E in the absence of shear. In buffer without urea, the 
mutant exhibits significantly increased susceptibility to proteolysis as compared to rVWF in 
denaturing buffer. Note that cleavage rates in both cases are comparable, even though a 200-fold 
lower ADAMTS13 concentration (0.05 U/ml) was used in case of the mutant. Best Michaelis-
Menten kinetic fits are shown as dotted lines. 
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Figure 3. Shear-induced cleavage of rVWF. (a) Cartoon illustrating VWF proteolysis under 
shear flow. The shear cell generates constant shear rates throughout the whole sample volume. 
Above a certain threshold, VWF unfolds, the A2 domains open and cleavage sites for 
ADAMTS13 are exposed. (b) Molar VWF concentrations at the end of each shear period are 
plotted as a function of the total duration of shear as shown here for γ!  = 0/s and 5000/s (1 U/ml 
ADAMTS13). (c) rVWF cleavage rates (1 U/ml ADAMTS13, 10 nM rVWF) as a function of 
applied shear rates. (d) Use of a tenfold higher protease concentration (10 U/ml) significantly 
increases cleavage rates. Exponential (dashed lines) and power law (bold dotted lines) fits are 
plotted. For shear rates γ! > 5000/s, VWF aggregation becomes dominant over VWF cleavage. (e) 
Multimer analysis of rVWF proteolysis in 25% NP under shear. Miniaturized gel data visualize 
the effect of increasing cleavage with increasing shear rate (bottom to top: γ!  = 0, 2700, 4000, 
7500, and 10,000/s). (f) Enlargement of the first plot depicts the time dependence of VWF 
breakdown at γ!  = 10,000/s. Note that performing the cleavage experiment in blood plasma 
prevents the formation of VWF aggregates. 
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Figure 4. Results of hydrodynamic simulations for the polymer response to shear flow. (a) The 
average tension fi is plotted as a function of bead position i along a polymer of size N = 20. The 
tension exhibits a complex profile that increases with increasing shear rate γ! . The standard 
deviation σ(fi), plotted at the bottom, indicates a broad distribution P(fi) of the tensile force, 
which are shown in (b) for the middle bead i = 10. (c) Snapshots of typical polymer 
configurations obtained at different shear rates as indicated. (d) The mean number of open 
cleavage sites nopen is plotted as a function of shear rate for different multimer sizes N. It exhibits 
a sigmoidal increase with increasing shear rates; sigmoidal fits according to Equation (4) are 
indicated by solid lines. nopen  denotes the weighted average according to the exponentially 
distributed VWF multimer sizes (blue line).  
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Figure 5. VWF proteolysis in blood plasma. (a) Kinetic analysis of rVWF cleavage in 25% NP 
(0.25 U/ml ADAMTS13) under denaturing conditions. Fitting Equation (1) (blue line) for fixed 
KM = 962 nM yields kcat = 0.0064/s. For comparison, the (lower) enzyme activity in buffer (1 
U/ml ADAMTS13) is shown (grey). (b) Protease activity in normal versus patient's AB plasma. 
The patient's plasma exhibited a six-fold reduced protease activity under denaturing conditions. 
(c) Shear-flow induced cleavage in blood plasma. For both NP and AB plasma, cleavage rate 
increases following a sigmoidal function, Equation (4), with increasing shear ( 2/1γ!  = 5522/s, γ!Δ  
= 1271/s, kmax = 0.0035 nM/s and kmax = 0.0014 nM/s for NP and AB respectively, fit: dotted 
lines) in good agreement with the Brownian hydrodynamic simulation assuming that the 
cleavage rate is described by Equation (1) with concentration of accessible VWF monomers 
given by Equations (5),(3), and (2). (dotted lines and open markers). 
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